General Announcement::Glenmark Pharmaceuticals receives ANDA approval for HAILEYTM Fe 1/20

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
22-Nov-2017 15:57:58
Status
New
Announcement Sub Title
Glenmark Pharmaceuticals receives ANDA approval for HAILEYTM Fe 1/20
Announcement Reference
SG171122OTHR9RAT
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
President & Global Chief Financial Officer
Effective Date and Time of the event
22/11/2017 12:00:00
Description (Please provide a detailed description of the event in the box below)
Sub: Glenmark Pharmaceuticals receives ANDA approval for HAILEYTM Fe 1/20 (Norethindrone Acetate and Ethinyl Estradiol Tablets, USP 1 mg/20 mcg and Ferrous Fumarate Tablets)

With reference to the subject mentioned above, kindly find attached media release which is self-explanatory.

Request you to kindly take the same on record.

Attachments

PR_22112017.pdf
Total size =600K